2.53
Finanzdaten der Edesa Biotech Inc-Aktie (EDSA)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums | 2025-06-30 | 2025-03-31 | 2024-12-30 | 2024-09-30 | 2024-06-30 |
Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
Research and Development |
93.90%
0.9391
|
0.4843 | 1.0198 | 0.1039 | 0.8973 |
Operating Income/Loss |
16.16%
-1.9037
|
-1.6389 | -1.8987 | -1.0044 | -1.9324 |
Nonoperating Income/Loss |
213.33%
0.1543
|
0.0492 | 0.2814 | 0.0423 | 0.2642 |
Income/Loss From Continuing Operations Before Tax |
10.05%
-1.7495
|
-1.5896 | -1.6173 | -0.9621 | -1.6682 |
Income Tax Expense/Benefit |
100.00%
-
|
0.0008 | - | - | - |
Income/Loss From Continuing Operations After Tax |
10.00%
-1.7495
|
-1.5904 | -1.6173 | -0.9621 | -1.6682 |
|
10.00%
-1.7495
|
-1.5904 | -1.6173 | -0.9621 | -1.6682 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
32.36%
7.0227
|
5.3058 | -0.9911 | 0.0168 | 3.2218 |
Basic Earnings Per Share |
16.67%
-0.25
|
-0.30 | -0.44 | -0.29 | -0.52 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):